BSE filing, BSE: 544673. Summary written from the filing by ALFA Finder's alert engine.
Modern Diagnostic & Research Centre Ltd: key numbers
- Share price
- ₹59.30
- Market cap
- ₹89.54 Cr
- Revenue (annual)
- ₹83.11 Cr
- Net profit (annual)
- ₹5.25 Cr
- P/E (TTM)
- 17.0×Sector 52.0×
- Promoter holding
- 72.95%
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Modern Diagnostic & Research Centre Ltd
All →Modern Diagnostic & Research Centre Other Announcement
The company submitted the Regulation 74(5) certificate for the half-year ended September 30, 2026, confirming depository participant compliance, alongside a nil investor grievance report.
Modern Diagnostic & Research Centre Annual General Meeting
Modern Diagnostic & Research Centre Limited conducted its 14th AGM on September 30, 2026. Shareholders transacted ordinary business, including the adoption of financial statements and auditor reappointment.
Modern Diagnostic & Research Centre Price Movement Clarification
Modern Diagnostic & Research Centre Ltd clarified its share price movement is purely market-driven. No undisclosed or price-sensitive information exists requiring disclosure under SEBI Regulations.
Modern Diagnostic & Research Centre Annual Report
Modern Diagnostic & Research Centre has submitted its Annual Report and Notice of the 14th Annual General Meeting for the financial year 2025-26.
Modern Diagnostic & Research Centre Annual General Meeting
Modern Diagnostic & Research Centre Limited has scheduled its 14th Annual General Meeting for September 30, 2026. The book closure is from September 24 to 30.
Modern Diagnostic & Research Centre Board Meeting Date
Modern Diagnostic & Research Centre Limited scheduled a board meeting for September 3, 2026, to discuss administrative agenda items including AGM notices and reports.
Other board meeting outcome announcements
All →R R Kabel Board Meeting Outcome
RR Kabel's board approved amendments to its UPSI fair disclosure code on 28 October 2026. The amended code is enclosed and posted on the company website.
M K Exim (India) Board Meeting Outcome
M.K. Exim (India) approved shifting its registered office within Jaipur to Plot J-1247, Sitapura. The board meeting was held on October 28, 2026.
United Spirits Board Meeting Outcome
United Spirits' board approved amendments to its insider trading code on 28 October 2026, effective 29 October 2026. The revised code is available on the company website.
SBI Funds Management Board Meeting Outcome
SBI Funds Management extended internal auditor Chhajed & Doshi's term to March 31, 2030. This routine decision was taken at the October 28, 2026 board meeting.
- Execution
- April 1, 2028 to March 31, 2030
Paras Healthcare Board Meeting Outcome
Paras Healthcare filed its board-approved UPSI fair disclosure code under Regulation 8(2). This routine governance policy update reports no business event.
Gateway Distriparks Board Meeting Outcome
Gateway Distriparks' board approved a revised Code of Practices for Fair Disclosure of UPSI under PIT Regulation 8(2). This is a routine governance policy update with no business event.